Literature DB >> 17186363

Do haplogroups H and U act to increase the penetrance of Alzheimer's disease?

Farzaneh Fesahat1, Massoud Houshmand, Mehdi Shafa Shariat Panahi, Kurosh Gharagozli, Farzaneh Mirzajani.   

Abstract

1. Alzheimer's disease (AD) is the most common form of dementia in the elderly in which interplay between genes and the environment is supposed to be involved. Mitochondrial DNA (mtDNA) has the only noncoding regions at the displacement loop (D-loop) region that contains two hypervariable segments (HVS-I and HVS-II) with high polymorphism. mtDNA has already been fully sequenced and many subsequent publications have shown polymorphic sites, haplogroups, and haplotypes. Haplogroups could have important implications to understand the association between mutability of the mitochondrial genome and the disease.2. To assess the relationship between mtDNA haplogroup and AD, we sequenced the mtDNA HVS-I in 30 AD patients and 100 control subjects. We could find that haplogroups H and U are significantly more abundant in AD patients (P = 0.016 for haplogroup H and P = 0.0003 for haplogroup U), Thus, these two haplogroups might act synergistically to increase the penetrance of AD disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17186363     DOI: 10.1007/s10571-006-9126-9

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   4.231


  21 in total

1.  Classification of European mtDNAs from an analysis of three European populations.

Authors:  A Torroni; K Huoponen; P Francalacci; M Petrozzi; L Morelli; R Scozzari; D Obinu; M L Savontaus; D C Wallace
Journal:  Genetics       Date:  1996-12       Impact factor: 4.562

2.  Population genetics and disease susceptibility: characterization of central European haplogroups by mtDNA gene mutations, correlation with D loop variants and association with disease.

Authors:  S Hofmann; M Jaksch; R Bezold; S Mertens; S Aholt; A Paprotta; K D Gerbitz
Journal:  Hum Mol Genet       Date:  1997-10       Impact factor: 6.150

3.  Evolutionary correlation between control region sequence and restriction polymorphisms in the mitochondrial genome of a large Senegalese Mandenka sample.

Authors:  L Graven; G Passarino; O Semino; P Boursot; S Santachiara-Benerecetti; A Langaney; L Excoffier
Journal:  Mol Biol Evol       Date:  1995-03       Impact factor: 16.240

4.  Sequence and organization of the human mitochondrial genome.

Authors:  S Anderson; A T Bankier; B G Barrell; M H de Bruijn; A R Coulson; J Drouin; I C Eperon; D P Nierlich; B A Roe; F Sanger; P H Schreier; A J Smith; R Staden; I G Young
Journal:  Nature       Date:  1981-04-09       Impact factor: 49.962

5.  Mitochondrial D-loop variation in Persian multiple sclerosis patients: K and A haplogroups as a risk factor!!

Authors:  Hassan Hassani-Kumleh; Massoud Houshmand; Mehdi Shafa Shariat Panahi; Gholam Hossein Riazi; Mohammad Hossein Sanati; Kurosh Gharagozli; Mojdeh Ghabaee
Journal:  Cell Mol Neurobiol       Date:  2006-05-06       Impact factor: 5.046

6.  Haplotype and phylogenetic analyses suggest that one European-specific mtDNA background plays a role in the expression of Leber hereditary optic neuropathy by increasing the penetrance of the primary mutations 11778 and 14484.

Authors:  A Torroni; M Petrozzi; L D'Urbano; D Sellitto; M Zeviani; F Carrara; C Carducci; V Leuzzi; V Carelli; P Barboni; A De Negri; R Scozzari
Journal:  Am J Hum Genet       Date:  1997-05       Impact factor: 11.025

7.  Alzheimer's brains harbor somatic mtDNA control-region mutations that suppress mitochondrial transcription and replication.

Authors:  Pinar E Coskun; M Flint Beal; Douglas C Wallace
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-09       Impact factor: 11.205

8.  Phylogenetic analysis of Leber's hereditary optic neuropathy mitochondrial DNA's indicates multiple independent occurrences of the common mutations.

Authors:  M D Brown; A Torroni; C L Reckord; D C Wallace
Journal:  Hum Mutat       Date:  1995       Impact factor: 4.878

9.  The role of cytochrome c oxidase deficient hippocampal neurones in Alzheimer's disease.

Authors:  D A Cottrell; G M Borthwick; M A Johnson; P G Ince; D M Turnbull
Journal:  Neuropathol Appl Neurobiol       Date:  2002-10       Impact factor: 8.090

10.  Neurofibrillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive function.

Authors:  David A Bennett; Julie A Schneider; Robert S Wilson; Julia L Bienias; Steven E Arnold
Journal:  Arch Neurol       Date:  2004-03
View more
  21 in total

1.  Mitochondrial genetic background plays a role in increasing risk to asthma.

Authors:  Emily Zifa; Zoe Daniil; Eleutheria Skoumi; Maria Stavrou; Kostantinos Papadimitriou; Marini Terzenidou; Konstantinos Kostikas; Vasileios Bagiatis; Konstantinos I Gourgoulianis; Zissis Mamuris
Journal:  Mol Biol Rep       Date:  2011-09-24       Impact factor: 2.316

2.  Huntington's disease and mitochondrial DNA deletions: event or regular mechanism for mutant huntingtin protein and CAG repeats expansion?!

Authors:  Mohammad Mehdi Banoei; Massoud Houshmand; Mehdi Shafa Shariat Panahi; Parvin Shariati; Maryam Rostami; Masoumeh Dehghan Manshadi; Tayebeh Majidizadeh
Journal:  Cell Mol Neurobiol       Date:  2007-10-20       Impact factor: 5.046

Review 3.  The Alzheimer's disease mitochondrial cascade hypothesis: progress and perspectives.

Authors:  Russell H Swerdlow; Jeffrey M Burns; Shaharyar M Khan
Journal:  Biochim Biophys Acta       Date:  2013-09-23

4.  Retrospective analysis of phytoSERM for management of menopause-associated vasomotor symptoms and cognitive decline: a pilot study on pharmacogenomic effects of mitochondrial haplogroup and APOE genotype on therapeutic efficacy.

Authors:  Yiwei Wang; Gerson Hernandez; Wendy J Mack; Lon S Schneider; Fei Yin; Roberta D Brinton
Journal:  Menopause       Date:  2020-01       Impact factor: 2.953

5.  Increased expression of ApoE and protection from amyloid-beta toxicity in transmitochondrial cybrids with haplogroup K mtDNA.

Authors:  Kunal Thaker; Marilyn Chwa; Shari R Atilano; Pinar Coskun; Javier Cáceres-Del-Carpio; Nitin Udar; David S Boyer; S Michal Jazwinski; Michael V Miceli; Anthony B Nesburn; Baruch D Kuppermann; M Cristina Kenney
Journal:  Neurobiol Dis       Date:  2016-04-22       Impact factor: 5.996

Review 6.  Mitochondria and cell bioenergetics: increasingly recognized components and a possible etiologic cause of Alzheimer's disease.

Authors:  Russell H Swerdlow
Journal:  Antioxid Redox Signal       Date:  2011-09-15       Impact factor: 8.401

Review 7.  Mitochondria, Cybrids, Aging, and Alzheimer's Disease.

Authors:  R H Swerdlow; S Koppel; I Weidling; C Hayley; Y Ji; H M Wilkins
Journal:  Prog Mol Biol Transl Sci       Date:  2017-02-01       Impact factor: 3.622

8.  Mitochondrial DNA and Alzheimer's disease: a first case-control study of the Tunisian population.

Authors:  Nesrine Ben Salem; Sami Boussetta; Itziar de Rojas; Sonia Moreno-Grau; Laura Montrreal; Narjes Mokni; Imene Mahmoud; Samia Younes; Nizar Daouassi; Mahbouba Frih-Ayed; Afef Hammami; Amel Ben Ammar Elgaaied; Agustín Ruiz; Lotfi Cherni
Journal:  Mol Biol Rep       Date:  2021-12-01       Impact factor: 2.316

9.  Clinic and genetic evaluation of variegate porphyria (VP) in a large family from the Balearic Islands.

Authors:  A Bonnin; A Picornell; J Orfila; J A Castro; M M Ramon
Journal:  J Inherit Metab Dis       Date:  2009-02-20       Impact factor: 4.982

10.  Mitochondrial genomic analysis of late onset Alzheimer's disease reveals protective haplogroups H6A1A/H6A1B: the Cache County Study on Memory in Aging.

Authors:  Perry G Ridge; Taylor J Maxwell; Christopher D Corcoran; Maria C Norton; Joann T Tschanz; Elizabeth O'Brien; Richard A Kerber; Richard M Cawthon; Ronald G Munger; John S K Kauwe
Journal:  PLoS One       Date:  2012-09-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.